(PR-inside.com) Ventria Bioscience (Ventria) is a biopharmaceutical company. It uses ExpressTec, a patented, plant-based recombinant protein manufacturing technology, for the production of recombinant proteins, small peptides, multi-subunit molecules, monoclonal antibodies, fusion proteins, and enzymes used in medicine and biotechnology. The company's internal Therapeutic Pipeline includes new human therapeutic products and vaccines for controlling zoonotic disease. Ventria also offers contract manufacturing services. Ventria's pipeline products include medicines: VEN100, VEN120, VEN130 and others; Bioreagents: Cellastim, Albumin-DX LR, Lacromin, Lysobac, Leukemia Inhibitory Factor (rhLIF), Optiferrin, Optibumin and others. It also manufactures biotherapeutics, biosimilars and bioindustrial products. Ventria is headquartered in Fort Collins, Colorado, the ..
